Scientists win £90,000 of funding for research into vital gene

News

Author: Geoffrey ChangPublished: 27 May 2015

Prep: Cook: Serves:

Scientists from Dundee University have been awarded more than £90,000 to research the genetics behind Parkinson’s disease.

Over the next three years, the team of scientists will use state-of-the-art technology to study how a gene known as ‘PINK1’ affects brain cells. It’s thought to lead to Parkinson’s when brain cells no longer respond to ‘PINK1’.

Dr Miratul Muqit, the lead researcher on the project, said: “In a cell you will see thousands of pathways, but we want to find the crucial ones. ‘PINK1’ is a gene that causes changes in the cells and we want to know if these changes disturb an essential pathway.”

The funds were awarded by British charity Parkinson’s UK.

Dr Arthur Roach, director of research and development at Parkinson’s UK, said: “Funding projects like this in Dundee is crucial if we are to progress in our research and one day find a cure.”

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

Do we have the right to test Parkinson’s medications on animals?

We explore the debate surrounding Parkinson’s and animal testing

Jessica Mann: writing with Parkinson’s

We talk to the British author about living with Parkinson’s for two decad

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

Unmasking the emotions of Parkinson’s

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Scientists win £90,000 of funding for research into vital gene

News

Author: Geoffrey ChangPublished: 27 May 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

Do we have the right to test Parkinson’s medications on animals?

Interviews

Jessica Mann: writing with Parkinson’s

Interviews

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Scientists win £90,000 of funding for research into vital gene

News

Author: Geoffrey ChangPublished: 27 May 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

Do we have the right to test Parkinson’s medications on animals?

Interviews

Jessica Mann: writing with Parkinson’s

Interviews

Frozen faces: 15 icy images that show what it’s like to lose control of your expressions

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Sign in